AIC
BIIB icon

Archer Investment Corporation’s Biogen BIIB Stock Holding History

Archer Investment Corporation’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,200
Closed -$340K – 792
2021
Q3 		$340K Hold
1,200
– – 0.13% 174
2021
Q2 		$416K Sell
1,200
-1,000
-45% -$303K 0.16% 148
2021
Q1 		$615K Sell
2,200
-169
-7% -$45.6K 0.25% 87
2020
Q4 		$580K Hold
2,369
– – 0.28% 89
2020
Q3 		$672K Buy
2,369
+245
+12% +$68.3K 0.35% 67
2020
Q2 		$568K Sell
2,124
-36
-2% -$10.8K 0.32% 72
2020
Q1 		$683K Buy
2,160
+160
+8% +$48.6K 0.46% 48
2019
Q4 		$593K Buy
2,000
+1,674
+513% +$464K 0.31% 77
2019
Q3 		$76K Buy
326
+26
+9% +$6.05K 0.05% 211
2019
Q2 		$90K Hold
300
– – 0.06% 208
2019
Q1 		$90K Hold
300
– – 0.06% 211
2018
Q4 		$90K Buy
+300
New +$95.7K 0.08% 194

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Archer Investment Corporation's BIIB Position: Q4 2021 in Review

Archer Investment Corporation sold out of Biogen (BIIB) in Q4 2021, closing a stake of 1,200 shares — an estimated $340K sold.

Archer Investment Corporation first reported a position in BIIB in Q4 2018 and held it in 12 quarters. The position peaked at $683K in Q1 2020. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Archer Investment Corporation reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Archer Investment Corporation sold 1,200 Biogen shares in Q4 2021, an estimated $340K.
  • Archer Investment Corporation first reported a position in Biogen in Q4 2018 and held it in 12 quarters.
  • Archer Investment Corporation's Biogen position peaked at $683K in Q1 2020.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Archer Investment Corporation's 13F filing for Q4 2021, filed 9 Feb 2022.